Outcomes of emergency department patients presenting with adverse drug events

Annals of Emergency Medicine

Volumn 58, Issue 3, 2011, Pages

  Hohl, Corinne M ^a,b,c   Nosyk, Bohdan ^d   Kuramoto, Lisa ^c   Zed, Peter J ^e   Brubacher, Jeffrey R ^a,b,c   Abu Laban, Riyad B ^a,b,c   Sheps, Samuel B ^a   Sobolev, Boris ^a,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

^c VANCOUVER COASTAL HEALTH RESEARCH INSTITUTE   (Canada)

^d CENTRE FOR HEALTH EVALUATION AND OUTCOME SCIENCES   (Canada)

^e DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE DRUG REACTION; ALGORITHM; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG INDICATION; EMERGENCY CARE; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; MORTALITY; OBSERVATIONAL STUDY; OUTPATIENT CARE; PHARMACIST; PHYSICIAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; RISK FACTOR; TREATMENT OUTCOME; TREATMENT REFUSAL;

EID: 79956373464     PISSN: 01960644     EISSN: 10976760     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2011.01.003     Document Type: Article

References (47)

1. J. Nebeker, P. Barach, and M. Samore Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting Ann Intern Med 140 2004 795 801
2. G.R. Baker, P.G. Norton, and V. Flintofy The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada CMAJ 170 2004 1678 1686
3. A. Forster, T. Asmis, and H. Clark Ottawa Hospital Patient Safety Study: incidence and timing of adverse events in patients admitted to a Canadian teaching hospital CMAJ 170 2004 1235 1240
4. J. Lazarou, B. Pomeranz, and P. Corey Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies JAMA 279 1998 1200 1205
5. L.L. Leape, T.A. Brennan, and N. Laird The nature of adverse events in hospitalized patients Results of the Harvard Medical Practice Study II N Engl J Med 324 1991 377 384
6. J.A. Johnson, and J.L. Bootman Drug-related morbidity and mortality: a cost-of-illness model Arch Intern Med 155 1995 1949 1956
7. D. Bates, N. Spell, and D. Cullen The costs of adverse drug events in hospitalized patients JAMA 277 1997 307 311
8. D. Classen, S. Pestotnik, and S. Evans Adverse drug events in hospitalized patients JAMA 277 1997 301 306
9. J.H. Gurwitz, T.S. Field, and L.R. Harrold Incidence and preventability of adverse drug events among older persons in the ambulatory setting JAMA 289 2003 1107-1016
10. C.A. Bond, and C.L. Raehl Adverse drug reactions in United States hospitals Pharmacotherapy 26 2006 601 608
11. J. Lundkvist, and B. Jonsson Pharmacoeconomics of adverse drug reactions Fundam Clin Pharmacol 18 2004 275 280
12. R. Bordet, S. Gauthier, and H.L. Louet Analysis of the direct cost of adverse drug reactions in hospitalized patients Eur J Clin Pharmacol 56 2001 935 941
13. M. Pirmohamed, S. James, and S. Meakin Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients BMJ 329 2004 15 19
14. L.J. Samoy, P.J. Zed, and K. Wilbur Drug-related hospitalizations in a tertiary care internal medicine service of a Canadian hospital: a prospective study Pharmacotherapy 26 2006 1578 1586
15. H. Dormann, U. Muth-Selbach, and S. Krebs Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting Drug Safety 22 2000 161 168
16. D.S. Budnitz, D.A. Pollock, and K.N. Weidenbach National surveillance of emergency department visits for outpatient adverse drug events JAMA 296 2006 1858 1866
17. Slone Epidemiology Center Patterns of medication use in the United States 2004: a report from the Slone Survey Slone Epidemiology Center at Boston University http://www.bu.edu/slone/SloneSurvey/AnnualRpt/SloneSurveyReport2004. pdf Accessed April 30, 2010
18. M.M. Burton, C. Hope, and M.D. Murray The cost of adverse drug events in ambulatory care AMIA Annu Symp Proc 11 2007 90 93
19. T.S. Field, B.H. Gilman, and S. Subramanian The costs associated with adverse drug events among older adults in the ambulatory setting Med Care 43 2005 1171 1176
20. P.J. Zed Drug-related visits to the emergency department J Pharm Pract 18 2005 329 335
21. P.J. Zed, R.B. Abu-Laban, and R.M. Balen Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study CMAJ 178 2008 1563 1569
22. K.C. Sikdar, R. Alaghehbandan, and D. MacDonald Adverse drug events in adult patients leading to emergency department visits Ann Pharmacother 44 2010 641 649
23. I.R. Edwards, and J.K. Aronson Adverse drug reactions: definitions, diagnosis, and management Lancet 356 2000 1255 1259
24. K.L. Lanctot, and C.A. Naranjo Comparison of the bayesian approach and a simple algorithm for assessment of adverse drug events Clin Pharmacol Ther 58 1995 692 698
25. C.A. Naranjo, U. Busto, and E.M. Seller A method for estimating the probability of adverse drug reactions Clin Pharmacol Ther 30 1981 239 245
26. World Health Organization International drug monitoring: the role of the hospital report of a World Health Organization meeting World Health Organ Tech Rep Ser 425 1966 5 24
27. C.M. Hohl, J. Dankoff, and A. Colacone Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department Ann Emerg Med 38 2001 666 671
28. C.M. Hohl, C. Robitaille, and V. Lord Emergency physician recognition of adverse drug-related events in elder patients presenting to an emergency department Acad Emerg Med 12 2005 197 205
29. C. Hepler, and L. Strand Opportunities and responsibilities in pharmaceutical care Am J Hosp Pharm 47 1990 533 543
30. C. Baliski, B. Nosyk, and A. Melck The cost-effectiveness of three strategies for the surgical treatment of symptomatic primary hyperparathyroidism Ann Surg Oncol 15 2008 2653-2360
31. C.M. Hohl, B. Nosyk, and M. Sadatsafavi A cost-effectiveness analysis of propofol versus midazolam for procedural sedation in the emergency department Acad Emerg Med 15 2008 32 39
32. M. Drummond, M. Sculpher, and G. Torrance Methods for the Economic Evaluation of Health Care Programmes 3rd ed. 2005 Oxford University Press Drummond, Oxford
33. D. Cox, and D. Oakes Analysis of Survival Data 1984 Chapman Hall London, England
34. D.W. Hosmer, and S. Lemeshow Applied Logistic Regression 2nd ed. 2000 John Wiley & Sons New York, NY
35. E. Vittinghoff, C. McCulloch, and D. Gidden Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models 2005 Springer New York, NY
36. C.M. Hohl, J. Brubacher, and J. Singer Emergency physicians attitudes about routine screening for adverse drug events CJEM 12 2010 260
37. D.W. Bates, D.J. Cullen, and N. Laird Incidence of adverse drug events and potential adverse drug events: implications for prevention JAMA 274 1995 29 34
38. D.S. Budnitz Assessing the National Electronic Injury Surveillance SystemCooperative Adverse Drug Event Surveillance projectsix sites, United States, January 1June 15, 2004 MMWR Morb Mortal Wkly Rep 54 2005 380 383
39. C.M. Hohl, P.J. Zed, and J.R. Brubacher Do emergency physicians attribute drug-related emergency department visits to medication-related problems? Ann Emerg Med 55 2010 493 502 e4
40. T.A. Young Estimating mean total costs in the presence of censoring: a comparative assessment of methods Pharmacoeconomics 23 2005 1229 1242
41. S. Schneeweiss, J.D. Seeger, and M. Maclure Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data Am J Epidemiol 154 2001 854 864
42. R.M. Poses, W.R. Smith, and D.K. McClish Controlling for confounding by indication for treatment: are administrative data equivalent to clinical data? Med Care 33 1995 AS36 AS46
43. H. Quan, G.A. Parsons, and W.A. Ghali Validity of information on comorbidity derived from ICD-9-CCM administrative data Med Care 40 2002 675 685
44. Canadian Institute for Health Information Coding Variations in the Discharge Abstract Database (DAD) Data 2003 Canadian Institute for Health Information Ottawa, Canada
45. A. Killpack, M. Budd, and R. Chapman Automating patient acuity in critical care units from nursing documentation Proc Annu Symp Comput Appl Med Care 1984 709 711
46. D. Miranda The therapeutic intervention scoring system: one single tool for the evaluation of workload, the work process and management? Intensive Care Med 23 1997 615 617
47. J.Y.F. Wu, W.Y.S. Leung, and S. Chang Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial BMJ 333 2006 522 528